Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma
Clinical trial NCT02758366 · TERMINATED
Trial details
- NCT number
- NCT02758366
- Sponsor
- Meyer Children's Hospital IRCCS
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2020-01-16
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.